Clovis Oncology (CLVS) Enters First Amended with Pfizer Over Licensing Agreement
Tweet Send to a Friend
Clovis Oncology (Nasdaq: CLVS) disclosed the following on Tuesday:Item 1.01 Entry into a Material Definitive Agreement.On ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
